Prosper AI Secures $30M

Prosper AI raises $30M led by Andreessen Horowitz to scale its AI platform managing the entire patient journey in healthcare.

3 min read
Screenshot of Prosper AI's dashboard showing patient scheduling and billing management features.
Prosper AI's platform aims to streamline the entire patient journey.

Prosper AI has secured $30 million in Series A funding, led by Andreessen Horowitz, to expand its AI platform designed to manage the complete patient journey in healthcare.

The company's platform integrates patient scheduling, insurance verification, and billing, coordinating voice interactions with both patients and insurers.

Related startups

Prosper AI platform interface showing patient journey management.
Image credit: Prosper AI

The investment follows a period of significant growth for Prosper AI, which reported a 5x revenue increase and added over 40 new healthcare organizations in the past six months.

The platform currently supports more than 150,000 healthcare providers and facilitates over $1.3 billion in patient care.

Beyond Scheduling: A Holistic Patient Journey Platform

Unlike earlier AI solutions focused solely on appointment scheduling, Prosper AI tackles the administrative complexities across the entire patient lifecycle.

This includes automating insurance verification and patient billing, aiming to reduce administrative waste estimated at over $450 billion annually in the U.S. healthcare system.

By automating these processes, Prosper AI helps providers cut administrative costs by over 40% and provides patients with upfront clarity on coverage and costs.

Customers include organizations like Preferred Dermatology, Jackson Memorial Hospital, and healthcare technology leaders such as Athenahealth.

Market Traction and Competitive Wins

Prosper AI reports winning 80% of competitive evaluations, highlighting its comprehensive approach.

"Prosper AI was the only platform capable of handling insurance verification, patient financial responsibility, and the broader workflows required to support the entire patient journey," said Jonathan Banta, CEO of The 44 Group.

Noah England, COO of Piedmont Dermatology, noted that Prosper AI handles over 50% of patient conversations end-to-end, including complex real-time benefits verification, significantly outpacing competitors stuck at lower automation rates.

Enterprise Adoption and Investor Confidence

Major healthcare technology companies are also adopting Prosper AI. Athenahealth selected the platform for its internal voice AI workflows, and Imagine Software chose it after side-by-side evaluations.

"In repeated side-by-side evaluations, Prosper AI achieved the highest accuracy and completion rates," stated Sam Khashman, CEO of ImagineSoftware.

Andreessen Horowitz partner Jay Rughani emphasized Prosper AI's ambition to eliminate administrative friction points, citing strong customer pull-through as a key indicator of its effectiveness. The firm has previously invested in AI companies like Town and Special OS AI.

Base10 Partners co-founder Adeyemi Ajao highlighted the use of agentic AI to drive savings, revenue, and patient experience improvements.

Future Growth and AI Workforce Vision

The new funding will support Prosper AI's expansion of engineering and customer-facing teams, deepen EHR integrations, and accelerate market adoption.

"Healthcare providers don't want separate tools for scheduling, insurance verification, and billing," said Xavier de Gracia, Prosper AI Co-Founder and Co-CEO. "They want a single platform capable of managing the workflows that determine whether care happens and whether providers ultimately get paid."

Prosper AI aims to build an AI workforce that streamlines healthcare operations, reduces waste, and increases access to care.

© 2026 StartupHub.ai. All rights reserved. Do not enter, scrape, copy, reproduce, or republish this article in whole or in part. Use as input to AI training, fine-tuning, retrieval-augmented generation, or any machine-learning system is prohibited without written license. Substantially-similar derivative works will be pursued to the fullest extent of applicable copyright, database, and computer-misuse laws. See our terms.